Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 534 clinical trials
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.

Despite good initial response, some patients with core binding factor and/or NPM1-mutated AML eventually relapse. Some of these patients can be identified earlier on, before overt cytological relapse, when followed for minimal residual disease. The outcome of patients treated when molecular relapse is confirmed, before overt cytological relapse, is not …

minimal residual disease
remission
residual tumor
cell transplantation
consolidation therapy
  • 0 views
  • 27 Jun, 2021
  • 1 location
Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.

  • 0 views
  • 31 May, 2021
  • 1 location
Oral Health Condition and Quality of Life in Children With Leukemia

Among the different types of cancer that most affect children, leukemia is the principal. One of the main treatments for leukemia is chemotherapy. Among the most common side effects of chemotherapy are nausea and/or vomiting, diarrhea, fatigue, alopecia, neuropathy, opportunistic infections, and oral mucositis. It is still necessary to establish …

cancer
lymphoid leukemia
  • 0 views
  • 26 Jul, 2021
  • 1 location
Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma

The French Public Health Council recommended pneumococcal vaccination combined strategy for all immunocompromised patients in 2012. This strategy consisted in conjugated 13-valent pneumococcal injection followed 2 months later by polysaccharide 23-valent vaccine injection. General practitioners are usually in charge of this vaccination. Conjugated pneumococcal vaccine enhances the immunogenicity of the …

diffuse large b cell lymphoma
leukemia
23-valent vaccine
polysaccharide
acute leukemia
  • 0 views
  • 16 Jun, 2021
  • 4 locations